Whitney Ijem Analyst Performance

Managing Directo at Canaccord Genuity Group

Whitney Ijem is a stock analyst at Canaccord Genuity Group in the medical sector, covering 27 publicly traded companies. Over the past year, Whitney Ijem has issued 31 stock ratings, including buy and hold recommendations. While full access to Whitney Ijem's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Whitney Ijem's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 53 Last 9 Years
Buy Recommendations: 79.25% 42 Buy Ratings
Companies Covered: 27 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	79.2%	42 ratings
Hold	20.8%	11 ratings
Sell	0.0%	0 ratings

Out of 53 total stock ratings issued by Whitney Ijem at Canaccord Genuity Group, the majority (79.2%) have been Buy recommendations, followed by 20.8% Hold.

Best & Worst Calls

Best Call
0000.0%
QURE
Dec 2018
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
WVE
Dec 2019
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	27 companies

Whitney Ijem, an analyst at Canaccord Genuity Group, currently covers 27 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 27 companies	100.0%

Whitney Ijem of Canaccord Genuity Group specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 21 companies	77.8%
MED - DRUGS 4 companies	14.8%
MED - GENERIC DRG 1 company	3.7%
PHARMACEUTICAL PREPARATIONS 1 company	3.7%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
PVLA Palvella Therapeutics	8/19/2025	Boost Price Target	$49.50	$66.00	Buy
GBIO Generation Bio	8/18/2025	Boost Price Target	$6.29	$10.00	Buy
PASG Passage Bio	8/14/2025	Lower Price Target	$7.06	$67.00	Buy
GUTS Fractyl Health	8/14/2025	Lower Price Target	$0.98	$6.00	Buy
RARE Ultragenyx Pharmaceutical	8/8/2025	Lower Price Target	$27.54	$128.00	Buy
VRTX Vertex Pharmaceuticals	8/6/2025	Lower Price Target	$386.10	$411.00	Hold
WVE WAVE Life Sciences	8/4/2025	Initiated Coverage	$8.63	$19.00	Buy
ALNY Alnylam Pharmaceuticals	8/1/2025	Boost Price Target	$395.69	$415.00	Buy
RCKT Rocket Pharmaceuticals	7/25/2025	Lower Price Target	$3.19	$10.00	Buy
RYTM Rhythm Pharmaceuticals	7/18/2025	Boost Price Target	$90.36	$105.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
VERV Verve Therapeutics	6/17/2025	Downgrade	$10.98	$13.00	Hold
TSHA Taysha Gene Therapies	6/3/2025	Boost Price Target	$2.79	$11.00	Buy
RCKT Rocket Pharmaceuticals	6/3/2025	Lower Price Target	$2.77	$11.00	Buy
NTLA Intellia Therapeutics	6/3/2025	Lower Price Target	$7.16	$54.00	Buy
TSHA Taysha Gene Therapies	5/16/2025	Boost Price Target	$2.56	$9.00	Buy
ARCT Arcturus Therapeutics	5/13/2025	Lower Price Target	$12.65	$66.00	Buy
RCKT Rocket Pharmaceuticals	5/12/2025	Lower Price Target	$7.29	$34.00	Buy
RGLS Regulus Therapeutics	4/30/2025	Reiterated Rating	$7.91	$11.00	Hold
VERV Verve Therapeutics	4/15/2025	Boost Price Target	$4.12	$39.00	Buy
RYTM Rhythm Pharmaceuticals	4/8/2025	Boost Price Target	$54.96	$92.00	Buy
ALNY Alnylam Pharmaceuticals	3/21/2025	Boost Price Target	$282.02	$390.00	Buy
RGLS Regulus Therapeutics	3/17/2025	Reiterated Rating	$1.45	$28.00	Buy
GBIO Generation Bio	3/17/2025	Reiterated Rating	$4.84	$90.00	Buy
TNYA Tenaya Therapeutics	3/13/2025	Lower Price Target	$0.64	$6.00	Buy
ARCT Arcturus Therapeutics	3/10/2025	Lower Price Target	$13.98	$68.00	Buy
RCKT Rocket Pharmaceuticals	3/3/2025	Lower Price Target	$9.45	$36.00	Buy
RYTM Rhythm Pharmaceuticals	2/27/2025	Boost Price Target	$53.12	$81.00	Buy
PVLA Palvella Therapeutics	2/20/2025	Initiated Coverage	$20.97	$39.00	Buy
RARE Ultragenyx Pharmaceutical	2/18/2025	Boost Price Target	$42.49	$136.00	Buy
ALNY Alnylam Pharmaceuticals	2/18/2025	Boost Price Target	$256.45	$385.00	Buy
VRTX Vertex Pharmaceuticals	2/11/2025	Upgrade	$458.84	$424.00	Hold

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.